A Rationally Designed ICAM1 Antibody Drug Conjugate Eradicates Late-Stage and Refractory Triple-Negative Breast Tumors In Vivo

By
Noshin Noorjahan
-
0
124
The authors reported the development of a rationally designed antibody drug conjugate for the treatment of late-stage and refractory TNBC.
[Science Advances]
Full Article